基因组预测抗菌药物耐药性:时机成熟了吗?
本文综述了下一代测序(NGS)技术用于预测临床分离株和样本抗菌药物耐药性的现状,介绍了当前方法和工作流程,并以结核分枝杆菌、金黄色葡萄球菌和淋病奈瑟菌为例说明临床应用,指出基因组耐药预测在常规患者护理中仍处于起步阶段但将在诊断微生物学中发挥越来越重要的作用。
要点
- NGS技术正从研究转向临床用于预测抗菌药物耐药性
- 临床实验室正在评估基因组耐药预测的准确性和实用性
- 基因组方法已在特定情况下为诊断检测增加价值
核心结论
- 基因组方法预测抗菌药物耐药性在常规患者护理中仍处于起步阶段,但已在特定情况下增加价值并将发挥越来越重要的作用。
研究设计与样本
- 本文为综述,描述了用于预测临床分离株和样本抗菌药物耐药性的基因组测序方法、当前方法和工作流程,并总结了临床应用现状。
主要发现
- 基因组耐药预测领域正在快速发展并从研究环境过渡到临床使用。
- 临床实验室正在评估基因组耐药预测的准确性、实用性,包括NGS方法、下游生物信息学流程组件以及应提供此类检测的临床场景。
- 文中以结核分枝杆菌、金黄色葡萄球菌和淋病奈瑟菌三个医学相关微生物为例进行了说明。
临床怎么用
- 临床微生物实验室应关注基因组耐药预测在特定情况下的应用价值,并评估将其纳入诊断检测的可行性。
局限性
- 基因组耐药预测在常规患者护理中仍处于起步阶段。
- 未来的进步需要缩短周转时间、降低成本并改进对临床可操作结果的分析和解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Next-generation sequencing (NGS) technologies are being used to predict antimicrobial resistance. The field is evolving rapidly and transitioning out of the research setting into clinical use. Clinical laboratories are evaluating the accuracy and utility of genomic resistance prediction, including methods for NGS, downstream bioinformatic pipeline components, and the clinical settings in which this type of testing should be offered. CONTENT: We describe genomic sequencing as it pertains to predicting antimicrobial resistance in clinical isolates and samples. We elaborate on current methodologies and workflows to perform this testing and summarize the current state of genomic resistance prediction in clinical settings. To highlight this aspect, we include 3 medically relevant microorganism exemplars: Mycobacterium tuberculosis, Staphylococcus aureus, and Neisseria gonorrhoeae. Last, we discuss the future of genomic-based resistance detection in clinical microbiology laboratories. SUMMARY: Antimicrobial resistance prediction by genomic approaches is in its infancy for routine patient care. Genomic approaches have already added value to the current diagnostic testing landscape in specific circumstances and will play an increasingly important role in diagnostic microbiology. Future advancements will shorten turnaround time, reduce costs, and improve our analysis and interpretation of clinically actionable results.
引用
- Ransom EM, Potter RF, Dantas G, et al. Genomic Prediction of Antimicrobial Resistance: Ready or Not, Here It Comes! Clin Chem. 2020. PMID: 32918462. doi:10.1093/clinchem/hvaa172
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。